Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.70B | $6.24B | $6.29B | $6.21B | $5.99B | $6.89B | $7.95B | $8.16B | $7.43B | $7.22B |
| Revenue growth | — | 9.5% | 0.7% | -1.3% | -3.6% | 15.1% | 15.3% | 2.7% | -8.9% | -2.8% |
| Gross profit | $1.40B | $1.47B | $1.37B | $1.31B | $1.27B | $1.33B | $1.49B | $1.75B | $1.79B | $1.83B |
| Gross margin | 24.6% | 23.6% | 21.8% | 21.1% | 21.2% | 19.3% | 18.8% | 21.4% | 24.1% | 25.3% |
| Operating income | $806M | $836M | $703M | $664M | $582M | $310M | $762M | $957M | $883M | $1.02B |
| Operating margin | 14.1% | 13.4% | 11.2% | 10.7% | 9.7% | 4.5% | 9.6% | 11.7% | 11.9% | 14.1% |
| Net income | $485M | $519M | $443M | $413M | $348M | $117M | $492M | $643M | $647M | $729M |
| Net margin | 8.5% | 8.3% | 7.0% | 6.7% | 5.8% | 1.7% | 6.2% | 7.9% | 8.7% | 10.1% |
| EPS (diluted) | $6.55 | $7.06 | $6.17 | $6.13 | $5.15 | $1.73 | $7.34 | $9.60 | $9.71 | $11.18 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $771M | $769M | $703M | $680M | $829M | $392M | $152M | $1.06B | $1.44B | $944M |
| Capital expenditures | $284M | $314M | $350M | $328M | $340M | $300M | $300M | $314M | $295M | $433M |
| Free cash flow | $487M | $455M | $353M | $352M | $489M | $92.0M | -$148M | $743M | $1.14B | $511M |
| Share buybacks | $8.00M | $123M | — | — | — | — | — | — | — | — |
| Dividends paid | $141M | $165M | $182M | $174M | $178M | $184M | $181M | $194M | $210M | $211M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $512M | $595M | $327M | $264M | $665M | $328M | $236M | $401M | $997M | $1.03B |
| Total assets | $5.78B | $6.08B | $5.73B | $6.04B | $6.86B | $7.00B | $7.56B | $7.64B | $7.44B | $7.90B |
| Total liabilities | — | — | — | $3.27B | $3.79B | $3.77B | $4.30B | $3.99B | $3.55B | $3.53B |
| Long-term debt | $1.85B | $1.74B | $1.93B | $1.77B | $1.75B | $1.74B | $1.94B | $1.74B | $1.79B | $1.74B |
| Shareholders' equity | $2.56B | $2.89B | $2.39B | $2.72B | $2.95B | $3.10B | $3.15B | $3.54B | $3.80B | $4.27B |
| Retained earnings | $2.90B | $3.26B | $3.54B | $3.78B | $3.96B | $3.90B | $4.21B | $4.65B | $5.09B | $5.61B |
| Shares (wtd avg diluted) | 74.1M | 73.5M | 71.8M | 67.4M | 67.6M | 67.8M | 67.0M | 67.0M | 66.6M | 65.2M |
Every figure is extracted from Ingredion Inc’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.